Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Nitroimidazoles (metronidazole and tinidazole) are the only recommended drugs for treating Trichomonas vaginalis infection, and previous samples that assessed resistance of such isolates have been limited in geographic scope. We assessed the prevalence of in vitro aerobic metronidazole and tinidazol...

Full description

Bibliographic Details
Main Authors: Robert D. Kirkcaldy, Peter Augostini, Lenore E. Asbel, Kyle T. Bernstein, Roxanne P. Kerani, Christie J. Mettenbrink, Preeti Pathela, Jane R. Schwebke, W. Evan Secor, Kimberly A. Workowski, Darlene Davis, Jim Braxton, Hillard S. Weinstock
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2012-06-01
Series:Emerging Infectious Diseases
Subjects:
Trichomonas vaginalis
drug resistance
metronidazole resistance, tinidazole resistance, antimicrobial drug resistance, sexually transmitted diseases, protozoa
metronidazole resistance
tinidazole resistance
antimicrobial drug resistance
Online Access:https://wwwnc.cdc.gov/eid/article/18/6/11-1590_article

Internet

https://wwwnc.cdc.gov/eid/article/18/6/11-1590_article

Similar Items